Guggenheim Capital’s Loxo Oncology, Inc LOXO Stock Holding History

Guggenheim Capital’s Portfolio LOXO Stock Details LOXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-24,432	Closed	-$3.42M	–	2264
2018 Q4	$3.42M	Sell	24,432 -2,480	-9%	-$376K	0.03%	763
2018 Q3	$4.6M	Buy	26,912 +1,650	+7%	+$277K	0.03%	769
2018 Q2	$4.38M	Sell	25,262 -4,191	-14%	-$630K	0.03%	803
2018 Q1	$3.4M	Sell	29,453 -5,367	-15%	-$571K	0.01%	1258
2017 Q4	$2.93M	Buy	34,820 +30,542	+714%	+$2.55M	0.01%	1376
2017 Q3	$394K	Buy	+4,278	New	+$332K	﹤0.01%	2469

Other funds holding LOXO

IUHSA

Itau Unibanco Holding S.A. Sao Paulo, Brazil $4.31B AUM 46.57% 1-Year Est. Return

Guggenheim Capital's LOXO Position: Q1 2019 in Review

Guggenheim Capital sold out of Loxo Oncology, Inc (LOXO) in Q1 2019, closing a stake of 24,432 shares — an estimated $3.42M sold.

Guggenheim Capital first reported a position in LOXO in Q3 2017 and held it in 6 quarters. The position peaked at $4.6M in Q3 2018. 1 fund tracked by Wall St. Rank holds LOXO as of Q1 2019.

Guggenheim Capital reported no remaining Loxo Oncology, Inc position as of Q1 2019 after selling out during the quarter.
Guggenheim Capital sold 24,432 Loxo Oncology, Inc shares in Q1 2019, an estimated $3.42M.
Guggenheim Capital first reported a position in Loxo Oncology, Inc in Q3 2017 and held it in 6 quarters.
Guggenheim Capital's Loxo Oncology, Inc position peaked at $4.6M in Q3 2018.
1 fund tracked by Wall St. Rank held Loxo Oncology, Inc as of Q1 2019.

Based on Guggenheim Capital's 13F filing for Q1 2019, filed 15 May 2019.